Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 219

Results For "ANDA"

2601 News Found

Amrita University launches wearable device for home monitoring of glucose and BP
Digitisation | March 02, 2022

Amrita University launches wearable device for home monitoring of glucose and BP

Patients can use the wearable, non-invasive device to measure six body parameters including blood glucose, blood pressure, heart rate, blood oxygen, respiratory rate and 6-lead ECG, from the comfort of their home


USFDA approves first generic version of Apokyn cartridges
Drug Approval | March 02, 2022

USFDA approves first generic version of Apokyn cartridges

TruPharma has commenced commercial marketing of Sage's approved generic cartridge product


Trivitron Healthcare acquires U.S. based The Kennedy Company
Clinical Trials | March 02, 2022

Trivitron Healthcare acquires U.S. based The Kennedy Company

This has further strengthened its manufacturing presence in the United States of America


Boehringer Ingelheim partners with Lifebit to capture health data
Biotech | March 01, 2022

Boehringer Ingelheim partners with Lifebit to capture health data

This collaboration aims at capturing translational disease insights from large external healthcare biobanks and maximizing value of data for drug discovery and precision medicine


USFDA approves CITI Biopharma’s Vonjo
Drug Approval | March 01, 2022

USFDA approves CITI Biopharma’s Vonjo

Vonjo is the first approved therapy to specifically address the needs of adult cytopenic myelofibrosis patients


Biocon Biologics acquires Viatris’ biosimilar assets for up to US $ 3.3 billion
News | February 28, 2022

Biocon Biologics acquires Viatris’ biosimilar assets for up to US $ 3.3 billion

BBL will gain Viatris’ global biosimilars business whose revenues are estimated to be USD 1 billion next year, along with its portfolio of in-licensed biosimilar assets


Cannabotech's IntegrativePain products reduce pain considerably
Biotech | February 28, 2022

Cannabotech's IntegrativePain products reduce pain considerably

The products are based on a combination of mushrooms and cannabinoids that have achieved a strong therapeutic effect using low concentrations of THC. The treatment is expected to be launched in Israel, US and UK in H2 2022


BDR Pharma launches enzalutamide in 160 mg strength
Biotech | February 28, 2022

BDR Pharma launches enzalutamide in 160 mg strength

This medicine was previously available in 40mg and 80mg strength, for which patients had to consume 2 tablets a day as per the approved dosage


Cabinet approves Ayushman Bharat Digital Mission at an outlay of Rs 1,600 cr.
Policy | February 27, 2022

Cabinet approves Ayushman Bharat Digital Mission at an outlay of Rs 1,600 cr.

Citizens will be able to create their ABHA (Ayushman Bharat Health Account) numbers, to which their digital health records can be linked


New data reinforces efficacy of Tezspire
Biotech | February 27, 2022

New data reinforces efficacy of Tezspire

These results are being presented at the 2022 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting